Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia

Clinical trial NCT01020539 · COMPLETED

Trial details

NCT number: NCT01020539
Sponsor: Columbia University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Myelodysplastic Syndrome Juvenile Myelomonocytic Leukemia

Start date: 2002-09-11
Primary completion: 2011-07-20
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.